Literature DB >> 21222209

[Benign bone tumors].

A A Kamand1, J Warzecha, S Schneider, W Daecke, A Meurer.   

Abstract

Benign bone tumors are neoplasms which have their origin in bone and lack criteria of malignant tumors, i.e. infiltrative growth pattern and distant metastases. They are classified according to the WHO criteria concerning the tumor matrix (osseous, cartilaginous, fibrous etc.). Traditionally there are also some non-neoplastic bone lesions which are classified as benign bone tumors and belonging to the group of tumor-like bone lesions. For the physician it is important to know those entities which are harmless, as well as those which can tend to re-occur or which ones can be locally destructive. Finally, some tumors are at risk of becoming malignant (large and proximal enchondromas or multiple tumors within a syndromal disease). Treatment is in most cases uncomplicated and can range between observation, curettage and sometimes extensive resection with complex defect reconstruction.

Entities:  

Mesh:

Year:  2011        PMID: 21222209     DOI: 10.1007/s00132-010-1737-7

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  12 in total

1.  Flexible intramedullary nailing for the treatment of unicameral bone cysts in long bones.

Authors:  A Roposch; V Saraph; W E Linhart
Journal:  J Bone Joint Surg Am       Date:  2000-10       Impact factor: 5.284

2.  Cannulation of simple bone cysts.

Authors:  H Tsuchiya; M E Abdel-Wanis; K Uehara; K Tomita; Y Takagi; H Yasutake
Journal:  J Bone Joint Surg Br       Date:  2002-03

Review 3.  Giant cell tumor of bone.

Authors:  Robert E Turcotte
Journal:  Orthop Clin North Am       Date:  2006-01       Impact factor: 2.472

4.  Radiologic and pathologic analysis of solitary bone lesions. Part I: internal margins.

Authors:  J E Madewell; B D Ragsdale; D E Sweet
Journal:  Radiol Clin North Am       Date:  1981-12       Impact factor: 2.303

5.  [Bilateral fibula graft. Biological reconstruction following resection of malignant bone tumors].

Authors:  P-U Tunn; T K Moesta; H Delbrück
Journal:  Chirurg       Date:  2006-10       Impact factor: 0.955

6.  A mutant PTH/PTHrP type I receptor in enchondromatosis.

Authors:  Sevan Hopyan; Nalan Gokgoz; Raymond Poon; Robert C Gensure; Chunying Yu; William G Cole; Robert S Bell; Harald Jüppner; Irene L Andrulis; Jay S Wunder; Benjamin A Alman
Journal:  Nat Genet       Date:  2002-02-19       Impact factor: 38.330

Review 7.  [Cartilage tumours of the bone. Diagnosis and therapy].

Authors:  A Streitbuerger; J Hardes; C Gebert; H Ahrens; W Winkelmann; G Gosheger
Journal:  Orthopade       Date:  2006-08       Impact factor: 1.087

8.  Cloning of the putative tumour suppressor gene for hereditary multiple exostoses (EXT1).

Authors:  J Ahn; H J Lüdecke; S Lindow; W A Horton; B Lee; M J Wagner; B Horsthemke; D E Wells
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

Review 9.  The current status of bone scintigraphy in malignant diseases.

Authors:  Bahar Dasgeb; Michael H Mulligan; Chun K Kim
Journal:  Semin Musculoskelet Radiol       Date:  2007-12       Impact factor: 1.777

Review 10.  MR imaging of primary bone tumors and tumor-like conditions in children.

Authors:  Sandra L Wootton-Gorges
Journal:  Magn Reson Imaging Clin N Am       Date:  2009-08       Impact factor: 2.266

View more
  1 in total

Review 1.  [Osteogenic tumors of bone].

Authors:  B Jobke; M Werner
Journal:  Radiologe       Date:  2016-06       Impact factor: 0.635

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.